Roy Galvin

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roy Galvin:

Company Role Class Num Shares Value Price $ Report Date Ownership
HAEMONETICS CORP EVP, Chief Commercial Officer Common Stock 12,811 $640,678 $50.01 31 Oct 2025 Direct
HAEMONETICS CORP EVP, Chief Commercial Officer Non-qualified Stock Option (Right to Buy) 12,317 16 May 2025 Direct

Insider Reports Filed by Roy Galvin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HAE HAEMONETICS CORP 31 Oct 2025 1 -$7,251 4 EVP, Chief Commercial Officer 03 Nov 2025, 16:19
HAE HAEMONETICS CORP 16 May 2025 2 $0 4/A EVP, Chief Commercial Officer 13 Jun 2025, 16:21
HAE HAEMONETICS CORP 15 May 2025 2 -$32,015 4 President, Global Plasma & BC 19 May 2025, 17:10
HAE HAEMONETICS CORP 01 Nov 2024 1 -$11,508 4 President, Global Plasma & BC 05 Nov 2024, 16:17
HAE HAEMONETICS CORP 17 May 2024 2 $0 4 President, Global Plasma & BC 21 May 2024, 17:49
HAE HAEMONETICS CORP 15 May 2024 1 -$20,649 4 President, Global Plasma & BC 17 May 2024, 17:08
HAE HAEMONETICS CORP 01 Nov 2023 1 -$13,822 4 President, Global Plasma & BC 03 Nov 2023, 16:36
HAE HAEMONETICS CORP 15 May 2023 2 $0 4 President, Global Plasma & BC 17 May 2023, 16:28
HAE HAEMONETICS CORP 01 Nov 2022 2 $0 4 President, Global Plasma & BC 03 Nov 2022, 16:54
HAE HAEMONETICS CORP 10 Oct 2022 0 $0 3 President, Global Plasma & BC 17 Oct 2022, 20:19